New chemo cocktail aims to tame aggressive head and neck tumors with fewer side effects
NCT ID NCT04356170
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This phase II trial tested a combination of three chemotherapy drugs (cisplatin, 5-fluorouracil, and docetaxel) at adapted doses in 105 patients with locally advanced head and neck cancer that could not be surgically removed. The goal was to see if this adjusted dosing could effectively shrink tumors while reducing severe toxicity. The study measured how many patients had a successful response at 8 weeks without serious side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
chemotherapy combination (cisplatin, 5-fluorouracil, docetaxel)
What this could lead to
If successful, this could provide a more tolerable chemotherapy regimen for patients with inoperable head and neck cancer, potentially improving treatment response while reducing severe side effects.
What could go wrong
This is a phase II trial with only 105 participants and no comparison group, so results are preliminary. The chemotherapy combination still carries significant toxicity risks, and success in this early stage does not guarantee broader effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER OF HEAD AND NECK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Leon Berard
Lyon, 69008, France